829
edits
Changes
Jump to navigation
Jump to search
no edit summary
==Description==
==Description==
Glucagonomas are very rare tumours of the alpha cells of the pancreatic islets of Langerhans that produce the hormone glucagon without appropriate regulation. The excessive secretion of glucogon is a form of topic paraneoplastic syndrome. The disease has been reported in ten dogs and it is therefore extremely rare.
Glucagonomas are very rare tumours of the alpha cells of the pancreatic islets of Langerhans that produce the hormone glucagon without appropriate regulation. The excessive secretion of glucogon is a form of topic paraneoplastic syndrome. The disease has been reported in approximately ten dogs and it is therefore extremely rare.
As in humans, glucagonoma is characterised by the formation of skin lesions collectively described as '''necrolytic migratory erythema''' (NME), a syndrome which is observed much more commonly in dogs with liver failure when it is termed '''hepataocutaneous syndrome'''. Glucagonoma accounts for approximately ten percent of cases of NME. Dogs with glucagonoma frequently show signs of [[Diabetes Mellitus|diabetes mellitus]] as glucagon is antagonistic to insulin.
As in humans, glucagonoma is characterised by the formation of skin lesions collectively described as '''necrolytic migratory erythema''' (NME)<ref>Byrne KP. '''Metabolic epidermal necrosis-hepatocutaneous syndrome.''' ''Vet Clin North Am Small Anim Pract. 1999 Nov;29(6):1337-55.''</ref>, a syndrome which is observed much more commonly in dogs with liver failure when it is termed '''hepataocutaneous syndrome'''. Glucagonoma accounts for approximately ten percent of cases of NME. Dogs with glucagonoma frequently show signs of [[Diabetes Mellitus|diabetes mellitus]] as glucagon is antagonistic to insulin.
==Signalment==
==Signalment==
==Treatment==
==Treatment==
'''Surgical excision''' is the treatment of choice, even though the tumour will often have metastasised by the time it is diagnosed. In cases that are amenable to resection, medical treatment may be attempted with subcutaneous injections of the somatostatin analogue '''octreotide'''<ref>Oberkirchner U, Linder KE, Zadrozny L, Olivry T. '''Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.''' ''Vet Dermatol. 2010 May 24''</ref>.
Animals with severe cutaneous lesions may benefit from supplementation with essential fatty acids and zinc.
==Prognosis==
==Prognosis==
The prognosis is generally poor as the tumour has usually metastasised by the time it is diagnosed.
==References==
==References==
<references/>
Ettinger, S.J, Feldman, E.C. (2005) '''Textbook of Veterinary Internal Medicine (6th edition, volume 2)''' ''Elsevier Saunders''
[[Category:Pancreas_-_Hyperplastic_and_Neoplastic_Pathology]][[Category:Endocrine_System_-_Pathology]]
[[Category:Pancreas_-_Hyperplastic_and_Neoplastic_Pathology]][[Category:Endocrine_System_-_Pathology]]